(Q47683243)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648459%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648459%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

4

R C L Holt

R. C. L. Holt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648459%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

L Watson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648459%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

K Tullus

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648459%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

S D Marks

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648459%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

C Pilkington

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648459%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M W Beresford

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648459%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

31 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648459%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Immunology

2 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648459%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648459%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648459%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

1019-1025

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648459%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10875-012-9710-3

2 February 2020

exact match

0 references

cites work

Cutting edge: suppression of T cell chemotaxis by sphingosine 1-phosphate

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Antagonism of sphingosine 1-phosphate receptor-2 enhances migration of neural progenitor cells toward an area of brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

The role of sphingolipids in respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

S1P1 receptor directs the release of immature B cells from bone marrow into blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

C5a/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-κB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Altered expression of TNF-alpha signaling pathway proteins in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Neuronal injury in chronic CNS inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Oral treatment for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-β in mouse experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

FTY720 exerts a survival advantage through the prevention of end-stage glomerular inflammation in lupus-prone BXSB mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Emerging role of high density lipoproteins as a player in the immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Immune regulation by sphingosine 1-phosphate and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

CCR7 with S1P1 signaling through AP-1 for migration of Foxp3+ regulatory T-cells controls autoimmune exocrinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Regulatory T-cell-associated cytokines in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

A novel lipid natriuretic factor in the renal medulla: sphingosine-1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

The role of sphingosine kinase 1 in patients with severe acute pancreatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Increased survival and reduced renal injury in MRL/lpr mice treated with a novel sphingosine-1-phosphate receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Intrathecal increase of sphingosine 1-phosphate at early stage multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R(-/-)) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Sphingosine-1-phosphate signalling induces the production of Lcn-2 by macrophages to promote kidney regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9710-3

BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus

21 January 2018

1 reference

12 December 2020

The sphingosine-1-phosphate receptor agonist FTY720 prevents the development of anti-glomerular basement membrane glomerulonephritis

1 reference

12 December 2020

The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents

1 reference

12 December 2020

Sphingosine 1-phosphate regulates inflammation-related genes in human endothelial cells through S1P1 and S1P3

1 reference

12 December 2020

Lysophospholipids increase IL-8 and MCP-1 expressions in human umbilical cord vein endothelial cells through an IL-1-dependent mechanism

1 reference

12 December 2020

In situ glomerular expression of activated NF-kappaB in human lupus nephritis and other non-proliferative proteinuric glomerulopathy

1 reference

12 December 2020

The sphingosine 1-phosphate receptor modulator FTY720 prevents iodide-induced autoimmune thyroiditis in non-obese diabetic mice

1 reference

12 December 2020

Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus

1 reference

12 December 2020

The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors

1 reference

12 December 2020

FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration.

1 reference

12 December 2020

Cytokine profile, Foxp3 and nuclear factor-kB ligand levels in multiple sclerosis subtypes

1 reference

12 December 2020

10.1007/S10875-012-9710-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648459%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference